📣 VC round data is live. Check it out!

Organo Valuation Multiples

Discover Organo's revenue and EBITDA valuation multiples and investment history, alongside public comparables like Algonquin Power & Utilities, Nuclearelectrica, TAQA Morocco, Northland Power and more.

Organo Overview

About Organo

Organo Corp is a Japan-based company mainly engaged in the water treatment engineering business. The company operates in two business divisions namely water treatment engineering and functional product. Its water treatment engineering business includes manufacturing, delivery and maintenance of pure water systems, ultra-pure water systems and wastewater treatment systems for industries, condensate de mineralizers for power stations, waterworks and sewage treatment systems for the public sector. The functional product business encompasses the sale of standardized water treatment equipment, water treatment chemicals, and food processing materials.


Founded

1941

HQ

Japan

Employees

2.2K

Financials (LTM)

Revenue: $1B
EBITDA: $256M

EV

$4B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Organo Financials

Organo reported last 12-month revenue of $1B and EBITDA of $256M.

In the same LTM period, Organo generated $415M in gross profit, $256M in EBITDA, and $182M in net income.

Revenue (LTM)


Organo P&L

In the most recent fiscal year, Organo reported revenue of $1B and EBITDA of $217M.

Organo is profitable as of last fiscal year, with gross margin of 34%, EBITDA margin of 21%, and net margin of 15%.

See analyst estimates for Organo
LTMLast FY202320242025202620272028
Revenue$1B$1B$915M$1B$1B
Gross Profit$415M$346M$261M$328M$395M
Gross Margin36%34%29%33%36%
EBITDA$256M$217M$150M$203M$242M
EBITDA Margin22%21%16%20%22%
EBIT Margin21%19%14%18%21%
Net Profit$182M$152M$100M$141M$173M
Net Margin16%15%11%14%16%
Net Debt-$36M---

Financial data powered by Morningstar, Inc.

Organo Stock Performance

Organo has current market cap of $5B, and enterprise value of $4B.

Market Cap Evolution


Organo's stock price is $98.84.

Organo share price decreased by 1.3% in the last 30 days, and increased by 74.5% in the last year.

Organo has an EPS (earnings per share) of $3.30.

See more trading valuation data for Organo
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$4B$5B-1.3%-1.3%15.3%74.5%$3.30

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Organo Valuation Multiples

Organo trades at 3.7x EV/Revenue multiple, and 16.5x EV/EBITDA.

See NTM and 2027E valuation multiples for Organo

EV / Revenue (LTM)


Organo Financial Valuation Multiples

As of June 2, 2026, Organo has market cap of $5B and EV of $4B.

Organo has a P/E ratio of 24.9x.

LTMLast FY202320242025202620272028
EV/Revenue3.7x4.1x4.6x4.2x3.8x
EV/EBITDA16.5x19.5x28.2x20.8x17.5x
EV/EBIT17.4x21.6x32.5x23.3x18.6x
EV/Gross Profit10.2x12.2x16.2x12.9x10.7x
P/E24.9x30.0x45.5x32.3x26.3x
EV/FCF54.0x36.6x(196.0x)47.0x54.2x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Organo Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Organo Margins & Growth Rates

Organo grew revenue by 10% and EBITDA by 16% in the last fiscal year.

In the most recent fiscal year, Organo reported gross margin of 34%, EBITDA margin of 21%, and net margin of 15%.

See estimated margins and future growth rates for Organo

Organo Margins

Last FY202420252026202720282029
Gross Margin34%33%36%35%
EBITDA Margin21%20%22%22%
EBIT Margin19%18%21%21%
Net Margin15%14%16%16%
FCF Margin11%9%7%10%

Organo Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth10%10%9%12%
Gross Profit Growth19%26%20%8%
EBITDA Growth16%35%19%13%
EBIT Growth22%40%25%13%
Net Profit Growth19%41%23%11%
FCF Growth(43%)(517%)(13%)55%

Data powered by FactSet, Inc. and Morningstar, Inc.

Organo Operational KPIs

Organo's revenue per employee in the last FY averaged $0.5M, while opex per employee averaged $0.1M for the same period.

Organo's Rule of 40 is 34% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Organo's Rule of X is 52% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Organo
LTMLast FY202320242025202620272028
Rule of 4035%34%---
Bessemer Rule of X53%52%---
Revenue per Employee-$0.5M---
Opex per Employee-$0.1M---
R&D Expenses to Revenue2%---2%
Opex to Revenue-15%14%15%14%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Algonquin Power & Utilities4.7x4.5x11.3x10.9x
Nuclearelectrica3.1x3.1x5.3x5.8x
TAQA Morocco4.6x4.5x14.9x14.6x
Northland Power4.9x4.8x9.6x8.8x
Weiming Group5.7x5.0x10.2x9.4x
TAURON0.8x0.9x3.8x4.1x
Kenon Holdings6.0x-16.5x-
Kyushu Electric Power1.5x1.6x7.9x8.1x

This data is available for Pro users. Sign up to see all Organo competitors and their valuation data.

Start Free Trial

Investments by Organo

Organo has invested in 1 company to date.

Latest investment by Organo was on November 18th 2024. Organo invested in LIGHTz in their $6M Series B round (EV/Revenue multiple available to Pro users).

See VC round multiples

Latest Investments by Organo

LIGHTz
Description
LIGHTz is a San Francisco-based platform facilitating technology transfer and information exchange using AI-driven matchmaking. The service connects research institutions with industry partners by analyzing patents, publications, and market needs to identify licensing opportunities. LIGHTz supports universities like Stanford and companies in biotech and cleantech sectors through automated deal sourcing and collaboration tools.
HQ CountryJapan
HQ City
Tsukuba
Deal Date18 Nov 2024
RoundSeries B
Raised$6M
InvestorsOrgano; Shoko Chukin Bank; Tokyo Boeki Holdings
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Organo investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Organo

When was Organo founded?Organo was founded in 1941.
Where is Organo headquartered?Organo is headquartered in Japan.
How many employees does Organo have?As of today, Organo has over 2K employees.
Is Organo publicly listed?Yes, Organo is a public company listed on Tokyo Stock Exchange.
What is the stock symbol of Organo?Organo trades under 6368 ticker.
When did Organo go public?Organo went public in 1961.
Who are competitors of Organo?Organo main competitors include Algonquin Power & Utilities, Nuclearelectrica, TAQA Morocco, Northland Power, Weiming Group, TAURON, Kenon Holdings, Kyushu Electric Power, Riyadh Cables, J-Power.
What is the current market cap of Organo?Organo's current market cap is $5B.
What is the current revenue of Organo?Organo's last 12 months revenue is $1B.
What is the current revenue growth of Organo?Organo revenue growth (NTM/LTM) is 12%.
What is the current EV/Revenue multiple of Organo?Current revenue multiple of Organo is 3.7x.
What is the current EBITDA of Organo?Organo's last 12 months EBITDA is $256M.
What is Organo's EBITDA margin?Organo's last 12 months EBITDA margin is 22%.
What is the current EV/EBITDA multiple of Organo?Current EBITDA multiple of Organo is 16.5x.
What is the current FCF of Organo?Organo's last 12 months FCF is $78M.
What is Organo's FCF margin?Organo's last 12 months FCF margin is 7%.
What is the current EV/FCF multiple of Organo?Current FCF multiple of Organo is 54.0x.
How many companies Organo has acquired to date?Organo hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Organo has invested to date?As of June 2026, Organo has invested in 1 company.
What was the last Organo investment?On 18th November 2024 Organo invested in LIGHTz, participating in a $6M Series B round, alongside Shoko Chukin Bank and Tokyo Boeki Holdings.
In what companies Organo invested in?Organo invested in LIGHTz.

See public comps similar to Organo

Lists including Organo

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial